Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952925003647 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849765768231649280 |
|---|---|
| author | Jessica S. Little Angelica Medina Pena E. Bridget Kim Andrew J. Yee Omar Nadeem Shonali Midha Adam S. Sperling Nikhil C. Munshi Noopur Raje Matthew J. Frigault Diana D. Cirstea Sarah P. Hammond |
| author_facet | Jessica S. Little Angelica Medina Pena E. Bridget Kim Andrew J. Yee Omar Nadeem Shonali Midha Adam S. Sperling Nikhil C. Munshi Noopur Raje Matthew J. Frigault Diana D. Cirstea Sarah P. Hammond |
| author_sort | Jessica S. Little |
| collection | DOAJ |
| format | Article |
| id | doaj-art-efef80ffec31459aaec96055da7006ca |
| institution | DOAJ |
| issn | 2473-9529 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Blood Advances |
| spelling | doaj-art-efef80ffec31459aaec96055da7006ca2025-08-20T03:04:46ZengElsevierBlood Advances2473-95292025-08-019164190419410.1182/bloodadvances.2025016748Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapyJessica S. Little0Angelica Medina Pena1E. Bridget Kim2Andrew J. Yee3Omar Nadeem4Shonali Midha5Adam S. Sperling6Nikhil C. Munshi7Noopur Raje8Matthew J. Frigault9Diana D. Cirstea10Sarah P. Hammond11Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Division of Infectious Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; Correspondence: Jessica S. Little, Brigham and Women’s Hospital, 75 Francis St, PBB-A4, Boston, MA 02115;Division of Infectious Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MADepartment of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MADepartment of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MADepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MADepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MADepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Division of Hematology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MADepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MADepartment of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MADepartment of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MADepartment of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MADepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MAhttp://www.sciencedirect.com/science/article/pii/S2473952925003647 |
| spellingShingle | Jessica S. Little Angelica Medina Pena E. Bridget Kim Andrew J. Yee Omar Nadeem Shonali Midha Adam S. Sperling Nikhil C. Munshi Noopur Raje Matthew J. Frigault Diana D. Cirstea Sarah P. Hammond Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy Blood Advances |
| title | Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy |
| title_full | Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy |
| title_fullStr | Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy |
| title_full_unstemmed | Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy |
| title_short | Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy |
| title_sort | invasive fungal disease is rare in patients with relapsed refractory multiple myeloma treated with bcma car t cell therapy |
| url | http://www.sciencedirect.com/science/article/pii/S2473952925003647 |
| work_keys_str_mv | AT jessicaslittle invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT angelicamedinapena invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT ebridgetkim invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT andrewjyee invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT omarnadeem invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT shonalimidha invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT adamssperling invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT nikhilcmunshi invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT noopurraje invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT matthewjfrigault invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT dianadcirstea invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy AT sarahphammond invasivefungaldiseaseisrareinpatientswithrelapsedrefractorymultiplemyelomatreatedwithbcmacartcelltherapy |